Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pruitt

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Annals of Surgical Oncology|September 8, 2006
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancerElizabeth G Grubbs, Zeinab Abdel-Wahab, Douglas S Tyler, et al.
Trends in Cell Biology|March 31, 2000
Understanding Ras: 'it ain't over 'til it's over'J M Shields, K Pruitt, A McFall, et al.
Transplantation|May 1, 1993
The effect of bursectomy on natural xenoreactive antibodies and vascularized rat cardiac xenograft rejection in the chickenS K Pruitt, D Weinstock, M M Suyemoto, et al.
Transplantation Proceedings|February 1, 1993
Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chickenS K Pruitt, D Weinstock, M M Suyemoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenograftsR B Brauer, W M Baldwin, M R Daha, et al.
The Journal of Urology|March 21, 2001
Multimodal therapy for stage IV adult Wilms tumorG V Raj, S K Pruitt, S Lilly, et al.
Transplantation|March 27, 1995
Complement in organ transplantation. Contributions to inflammation, injury, and rejectionW M Baldwin, S K Pruitt, R B Brauer, et al.
Oncogene|December 24, 2013
The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migrationM Saxena, S S Dykes, S Malyarchuk, et al.
American Journal of Surgery|November 18, 2004
Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanomaTomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Journal of Surgical Oncology|June 11, 1999
MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastasesX D Dong, Z Abdel-Wahab, P Dematos, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|September 8, 2006
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancerElizabeth G Grubbs, Zeinab Abdel-Wahab, Douglas S Tyler, et al.
Trends in Cell Biology|March 31, 2000
Understanding Ras: 'it ain't over 'til it's over'J M Shields, K Pruitt, A McFall, et al.
Transplantation|May 1, 1993
The effect of bursectomy on natural xenoreactive antibodies and vascularized rat cardiac xenograft rejection in the chickenS K Pruitt, D Weinstock, M M Suyemoto, et al.
Transplantation Proceedings|February 1, 1993
Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chickenS K Pruitt, D Weinstock, M M Suyemoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenograftsR B Brauer, W M Baldwin, M R Daha, et al.
The Journal of Urology|March 21, 2001
Multimodal therapy for stage IV adult Wilms tumorG V Raj, S K Pruitt, S Lilly, et al.
Transplantation|March 27, 1995
Complement in organ transplantation. Contributions to inflammation, injury, and rejectionW M Baldwin, S K Pruitt, R B Brauer, et al.
Oncogene|December 24, 2013
The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migrationM Saxena, S S Dykes, S Malyarchuk, et al.
American Journal of Surgery|November 18, 2004
Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanomaTomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Journal of Surgical Oncology|June 11, 1999
MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastasesX D Dong, Z Abdel-Wahab, P Dematos, et al.
Pageof 9